Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
Alzheimer'S Research & Therapy
|
July 31, 2024
Comparing regional brain uptake of incretin receptor agonists after intranasal delivery in CD-1 mice and the APP/PS1 mouse model of Alzheimer's disease
Noor Abdulhameed, Alice Babin, Kim Hansen, et al.
Molecular and Cellular Neurosciences
|
August 11, 2010
EHD1 is a synaptic protein that modulates exocytosis through binding to snapin
Shunhui Wei, Yue Xu, Hong Shi, et al.
Hippocampus
|
January 22, 2014
Dysbindin-1 loss compromises NMDAR-dependent synaptic plasticity and contextual fear conditioning
W Bailey Glen, Bryant Horowitz, Gregory C Carlson, et al.
Tissue Barriers
|
December 14, 2023
Brain uptake pharmacokinetics of albiglutide, dulaglutide, tirzepatide, and DA5-CH in the search for new treatments of Alzheimer's and Parkinson's diseases
Elizabeth M Rhea, Alice Babin, Peter Thomas, et al.
Genome Biology
|
September 5, 2013
Measuring cell-type specific differential methylation in human brain tissue
Carolina M Montaño, Rafael A Irizarry, Walter E Kaufmann, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
October 14, 2021
Brain energy failure in dementia syndromes: Opportunities and challenges for glucagon-like peptide-1 receptor agonists
Hussein N Yassine, Victoria Solomon, Angad Thakral, et al.
The Journal of Biological Chemistry
|
April 10, 2014
Mutations in the BLOC-1 subunits dysbindin and muted generate divergent and dosage-dependent phenotypes
Jennifer Larimore, Stephanie A Zlatic, Avanti Gokhale, et al.
The American Journal of Pathology
|
September 27, 2008
Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer's disease
Natalia Louneva, Julia W Cohen, Li-Ying Han, et al.
Hippocampus
|
November 5, 2010
Akt1 deficiency in schizophrenia and impairment of hippocampal plasticity and function
Darrick T Balu, Gregory C Carlson, Konrad Talbot, et al.
Human Molecular Genetics
|
July 21, 2009
Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to dysbindin-1 mRNA expression
Junxia Tang, Robert P LeGros, Natalia Louneva, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
Alzheimer'S Research & Therapy
|
July 31, 2024
Comparing regional brain uptake of incretin receptor agonists after intranasal delivery in CD-1 mice and the APP/PS1 mouse model of Alzheimer's disease
Noor Abdulhameed, Alice Babin, Kim Hansen, et al.
Molecular and Cellular Neurosciences
|
August 11, 2010
EHD1 is a synaptic protein that modulates exocytosis through binding to snapin
Shunhui Wei, Yue Xu, Hong Shi, et al.
Hippocampus
|
January 22, 2014
Dysbindin-1 loss compromises NMDAR-dependent synaptic plasticity and contextual fear conditioning
W Bailey Glen, Bryant Horowitz, Gregory C Carlson, et al.
Tissue Barriers
|
December 14, 2023
Brain uptake pharmacokinetics of albiglutide, dulaglutide, tirzepatide, and DA5-CH in the search for new treatments of Alzheimer's and Parkinson's diseases
Elizabeth M Rhea, Alice Babin, Peter Thomas, et al.
Genome Biology
|
September 5, 2013
Measuring cell-type specific differential methylation in human brain tissue
Carolina M Montaño, Rafael A Irizarry, Walter E Kaufmann, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
October 14, 2021
Brain energy failure in dementia syndromes: Opportunities and challenges for glucagon-like peptide-1 receptor agonists
Hussein N Yassine, Victoria Solomon, Angad Thakral, et al.
The Journal of Biological Chemistry
|
April 10, 2014
Mutations in the BLOC-1 subunits dysbindin and muted generate divergent and dosage-dependent phenotypes
Jennifer Larimore, Stephanie A Zlatic, Avanti Gokhale, et al.
The American Journal of Pathology
|
September 27, 2008
Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer's disease
Natalia Louneva, Julia W Cohen, Li-Ying Han, et al.
Hippocampus
|
November 5, 2010
Akt1 deficiency in schizophrenia and impairment of hippocampal plasticity and function
Darrick T Balu, Gregory C Carlson, Konrad Talbot, et al.
Human Molecular Genetics
|
July 21, 2009
Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to dysbindin-1 mRNA expression
Junxia Tang, Robert P LeGros, Natalia Louneva, et al.
Page
of 4